|
|
||||||||
1 Department of Medicine and 2 Departments of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, and 3 Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29425
The development of vascular disease is
accelerated in hyperglycemic states. Vascular injury plays a pivotal
role in the progression of atherosclerotic vascular disease in
diabetes, which is characterized by increased vascular smooth muscle
cell (VSMC) proliferation and extracellular matrix accumulation. We
previously reported that diabetes alters the activity of the
kallikrein-kinin system and results in the upregulation of kinin
receptors in the vessel wall. To determine whether glucose can directly
influence the regulation of kinin receptors, the independent effect of
high glucose (25 mM) on B2-kinin receptors (B2KR) in VSMC
was examined. A threefold increase in B2KR protein levels and a 40%
increase in B2KR surface receptors were observed after treatment with
high glucose after 24 h. The mRNA levels of B2KR were also
significantly increased by high glucose as early as 4 h later. To
elucidate the cellular mechanisms by which glucose regulates B2KR, we
examined the role of protein kinase C (PKC). High glucose increased
total PKC activity and resulted in the translocation of conventional PKC isoforms (
1 and
2), novel (
), and
atypical (
) PKC isoforms into the membrane. Inhibition of
PKC activity prevented the increase in B2KR levels induced by ambient
high glucose. These findings provide the first evidence that glucose
regulates the expression of B2 receptors in VSMC and
provide a rationale to further study the interaction between glucose
and kinins on the pathogenesis of atherosclerotic vascular disease in diabetes.
protein kinase C; bradykinin; intracellular calcium
This article has been cited by other articles:
![]() |
J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koch, M. Wendorf, A. Dendorfer, S. Wolfrum, K. Schulze, F. Spillmann, H.-P. Schultheiss, and C. Tschope Cardiac kinin level in experimental diabetes mellitus: role of kininases Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H418 - H423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Baptista, M. C. W. Avellar, R. C. Araujo, J. L. Pesquero, J. P. Schanstra, J. L. Bascands, J. P. Esteve, A. C. M. Paiva, M. Bader, and J. B. Pesquero Transcriptional Regulation of the Rat Bradykinin B2 Receptor Gene: Identification of a Silencer Element Mol. Pharmacol., December 1, 2002; 62(6): 1344 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Aschner, T. K. Smith, N. Kovacs, J. M. B. Pinheiro, and M. Fuloria Mechanisms of bradykinin-mediated dilation in newborn piglet pulmonary conducting and resistance vessels Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L373 - L382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |